000 00968 a2200253 4500
005 20250517212800.0
264 0 _c20190802
008 201908s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mdy122
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEfstathiou, E
245 0 0 _aThe case for 'successfully' treating hormone naïve metastatic prostate cancer.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_c05 2018
300 _a1084-1086 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAndrostenes
650 0 4 _aDocetaxel
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 29
_gno. 5
_gp. 1084-1086
856 4 0 _uhttps://doi.org/10.1093/annonc/mdy122
_zAvailable from publisher's website
999 _c28319619
_d28319619